Effect of glucagon‐like peptide‐1 receptor agonists on fat distribution in patients with type 2 diabetes: A systematic review and meta‐analysis

AIMS/INTRODUCTION: Glucagon‐like peptide‐1 receptor agonists (GLP‐1Ras) are widely used to treat type 2 diabetes. They not only reduce glucose, but also have a positive effect on weight loss. However, few studies have reported the effect of GLP‐1Ras on fat distribution. MATERIALS AND METHODS: PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Kaixin, Yan, Xiaolu, Gao, Zhe, Hou, Yilin, Lv, Xiuqin, Song, Guangyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248433/
https://www.ncbi.nlm.nih.gov/pubmed/35191185
http://dx.doi.org/10.1111/jdi.13775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248433/
https://www.ncbi.nlm.nih.gov/pubmed/35191185
http://dx.doi.org/10.1111/jdi.13775

Ejemplares similares